Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) - medicine shortage information
Back to CRITICAL Shortages Back to ALL Shortages
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.
In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"
||Supply Impact Dates
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
Merck Sharp & Dohme (Australia) Pty Ltd
01 Jan 2019
31 Dec 2021
Unexpected Increase in Demand
TGA Management Actions:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.